v3.26.3
Consolidated Statement of Cash Flows
 12 Months Ended
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Cash flows from operating activities:    
Net loss $ (13,451,931) $ (369,632)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Share-based compensation 351,600 163,772
Goodwill impairment 5,362,000  
Depreciation and amortization expense 662,955 662,890
Non-cash rent expense 102,612 114,363
Change in fair value of accompanying warrant liability (1,730,321) (956,340)
Change in fair value of contingent consideration (198,888) 716,654
Effect of foreign currency remeasurement 603,313 242,348
Changes in assets and liabilities:    
Accounts receivable, non-trade (801,483) 114,936
Prepaid expenses 350,421 (453,058)
Accounts payable (768,785) (917,663)
Accrued expenses and other current liabilities (2,579,080) 1,486,656
Operating lease liabilities (116,314) (123,304)
Deferred tax liability (139,173) (468,427)
Contingent consideration   (133,080)
Other non-current liabilities   (2,886)
Net cash (used in) provided by operating activities (12,353,074) 77,229
Cash flows from financing activities:    
Proceeds from the sale of equity, net of subscriptions receivable and issuance costs 17,915,883 1,528,276
Net cash provided by financing activities 17,915,883 1,528,276
Effect of exchange rate on changes in cash, cash equivalents, and restricted cash 14,032 (3,750)
Net increase in cash, cash equivalents, and restricted cash 5,576,841 1,601,755
Cash, cash equivalents, and restricted cash, beginning of period 14,288,690 12,686,935
Cash, cash equivalents, and restricted cash, end of period 19,865,531 14,288,690
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 19,865,531 14,210,745
Restricted cash   77,945
Total cash, cash equivalents, and restricted cash 19,865,531 14,288,690
Supplemental cash flow data:    
Cash paid for interest expense $ 3,857 $ 17,433